QeA to EU Commission – Protecting coeliac consumers and gluten-free logos

Question for written answer to the Commission Giovanni La Via (PPE) - 18th February 2016 Subject:Β  Products containing gluten: protecting coeliac consumers Coeliac disease is an auto-immune disorder that affects 1% of the European population, in which the immune system can cause malabsorption and increases the risk of nutrient deficiencies, anaemia and osteoporosis, given that … Continue reading QeA to EU Commission – Protecting coeliac consumers and gluten-free logos

FDA – Methylsyneprhine in food supplements warning letters

This week the US Food and Drug Administration (FDA) issued several warning letters similar to the one below, to food business operators marketing food supplements containing methylsynephrine. "This letter concerns your product XXX which is labeled and/or offered for sale as a dietary supplement.Β The ingredient list on your product labeling declares methylsynephrine as a dietary … Continue reading FDA – Methylsyneprhine in food supplements warning letters